Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 1/20 | 0.33 |
| ▸ | TOP2A | P11388 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 3/20 | 0.31 |
| ▸ | TDO2 | P48775 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24252205 | 0.90 | LMNA (0.31) | — | |
| SCHEMBL23961924 | 0.89 | SLC9A1 (0.39) | SLC9A1TOP2A | |
| SCHEMBL23962156 | 0.89 | MAP3K5 (0.33) | TOP2A | |
| SCHEMBL22643744 | 0.89 | SLC9A1 (0.35) | SLC9A1TOP2AIDO1TDO2 | |
| SCHEMBL24115412 | 0.88 | MAP3K5 (0.33) | — | |
| SCHEMBL23604940 | 0.87 | MAP3K5 (0.32) | — | |
| SCHEMBL24974789 | 0.86 | SLC9A1 (0.34) | SLC9A1TOP2AIDO1TDO2 | |
| SCHEMBL23961890 | 0.85 | — | — | |
| SCHEMBL22210697 | 0.84 | SLC9A1 (0.35) | SLC9A1TOP2AIDO1TDO2 | |
| SCHEMBL21152761 | 0.83 | MAP3K5 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210332080-A1 | HYDROPHILIC LINKERS FOR ANTIBODY DRUG CONJUGATES | REGENERON PHARMACEUTICALS, INC. | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332080-A1 | HYDROPHILIC LINKERS FOR ANTIBODY DRUG CONJUGATES | CD44, CD47, EPCAM | SLC9A1 1849/4885TOP2A 594/4885IDO1 4286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.